Disability

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutionsStryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a…

10 months ago
Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed PatientsOragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

• Falls and car accidents lead incidence of concussions in emergency departments • Spray-dried drug formulation allows for easy delivery to patients…

10 months ago
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic strokeBioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke

Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke

 Planned Data Monitoring Committee (DMC) meeting recommended continuation of the study after reviewing data from the first 8 patients  Interim data…

10 months ago
ABLE United Marks $100 Million Savings Milestone on Inaugural National ABLE Savings DayABLE United Marks $100 Million Savings Milestone on Inaugural National ABLE Savings Day

ABLE United Marks $100 Million Savings Milestone on Inaugural National ABLE Savings Day

Florida's ABLE program reaches a major milestone, empowering individuals with disabilities and their families to save for future expenses, while…

10 months ago
Enlyte Celebrates National Adjuster Day by Launching Streamlined DecisionPoint InterfaceEnlyte Celebrates National Adjuster Day by Launching Streamlined DecisionPoint Interface

Enlyte Celebrates National Adjuster Day by Launching Streamlined DecisionPoint Interface

Revised system is designed to empower adjuster decision-making and increase productivity SAN DIEGO, Aug. 16, 2024 /PRNewswire/ -- Adjusters are often…

10 months ago
Remote access, real impacts: Assessing telehealth attitudes and usage in Northwest ColoradoRemote access, real impacts: Assessing telehealth attitudes and usage in Northwest Colorado

Remote access, real impacts: Assessing telehealth attitudes and usage in Northwest Colorado

New report identifies benefits and concerns regarding telehealth, provides recommendations for improving perceptions  DENVER, Aug. 14, 2024 /PRNewswire/ -- The Office…

10 months ago
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature RangeOragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14,…

10 months ago
Uplifting Military and Disability Communities: The N2 Company Launches Salute & Uniquely You MagazinesUplifting Military and Disability Communities: The N2 Company Launches Salute & Uniquely You Magazines

Uplifting Military and Disability Communities: The N2 Company Launches Salute & Uniquely You Magazines

IRVING, Texas, Aug. 13, 2024 /PRNewswire/ -- The N2 Company (N2) recently launched two groundbreaking monthly magazines, Salute and Uniquely You,…

10 months ago
Theralase(R) Release’s 2Q2024 Financial StatementsTheralase(R) Release’s 2Q2024 Financial Statements

Theralase(R) Release’s 2Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / August 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

10 months ago
Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity TestingOragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

The potential addressable market opportunity for ONP-002 includes an estimated 69 million concussions globallySARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE)…

10 months ago